ABR-215757

· Active Biotech AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABR-215757, covering 2015-06-25 to 2015-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) [Phase 2]

See pricing